人乳头瘤病毒疫苗临床应用中国专家共识

2021-03-15 中华医学会妇科肿瘤学分会 中国妇产科临床杂志

人乳头瘤病毒(human papilloma virus, HPV)疫苗接种是预防HPV感染和相关疾病的有效方法,是防控HPV感染相关疾病的一级预防措施。

中文标题:

人乳头瘤病毒疫苗临床应用中国专家共识

发布日期:

2021-03-15

简要介绍:

人乳头瘤病毒(human papilloma virus, HPV)疫苗接种是预防HPV感染和相关疾病的有效方法,是防控HPV感染相关疾病的一级预防措施。低龄人群接种HPV疫苗的效果优于高龄人群,性暴露前接种免疫效果最佳。HPV疫苗不仅适用于一般普通人群,同样推荐用于高危、特殊人群。对具有遗传易感、高危生活方式和人类免疫缺陷病毒感染的适龄女性应优先推荐接种HPV疫苗。不论是否有HPV感染、细胞学是否异常的适龄女性均可接种HPV疫苗。近期有妊娠计划和妊娠期、哺乳期女性不宜接种HPV疫苗。接种HPV疫苗后仍应进行子宫颈癌筛查。 

下载附件:

(因为版权问题,不支持下载)

评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1232248, encodeId=7970123224832, content=下载的文献是肺癌治疗的,不要下载了,标题与内容不符合。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5d78236143, createdName=ms7000000493469464, createdTime=Wed Jul 13 15:21:06 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229596, encodeId=2f671229596cb, content=文不对题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b876453242, createdName=ms1000001105984899, createdTime=Wed Jun 29 23:12:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204373, encodeId=978912043e310, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c626397577, createdName=ms7000001942545043, createdTime=Sun Mar 20 16:57:51 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204011, encodeId=e5641204011ea, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c0b6157478, createdName=ms3000000367833399, createdTime=Sat Mar 19 12:26:34 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189368, encodeId=16e8118936832, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:46:10 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-07-13 ms7000000493469464

    下载的文献是肺癌治疗的,不要下载了,标题与内容不符合。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1232248, encodeId=7970123224832, content=下载的文献是肺癌治疗的,不要下载了,标题与内容不符合。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5d78236143, createdName=ms7000000493469464, createdTime=Wed Jul 13 15:21:06 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229596, encodeId=2f671229596cb, content=文不对题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b876453242, createdName=ms1000001105984899, createdTime=Wed Jun 29 23:12:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204373, encodeId=978912043e310, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c626397577, createdName=ms7000001942545043, createdTime=Sun Mar 20 16:57:51 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204011, encodeId=e5641204011ea, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c0b6157478, createdName=ms3000000367833399, createdTime=Sat Mar 19 12:26:34 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189368, encodeId=16e8118936832, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:46:10 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-06-29 ms1000001105984899

    文不对题

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1232248, encodeId=7970123224832, content=下载的文献是肺癌治疗的,不要下载了,标题与内容不符合。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5d78236143, createdName=ms7000000493469464, createdTime=Wed Jul 13 15:21:06 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229596, encodeId=2f671229596cb, content=文不对题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b876453242, createdName=ms1000001105984899, createdTime=Wed Jun 29 23:12:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204373, encodeId=978912043e310, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c626397577, createdName=ms7000001942545043, createdTime=Sun Mar 20 16:57:51 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204011, encodeId=e5641204011ea, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c0b6157478, createdName=ms3000000367833399, createdTime=Sat Mar 19 12:26:34 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189368, encodeId=16e8118936832, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:46:10 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-03-20 ms7000001942545043

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1232248, encodeId=7970123224832, content=下载的文献是肺癌治疗的,不要下载了,标题与内容不符合。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5d78236143, createdName=ms7000000493469464, createdTime=Wed Jul 13 15:21:06 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229596, encodeId=2f671229596cb, content=文不对题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b876453242, createdName=ms1000001105984899, createdTime=Wed Jun 29 23:12:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204373, encodeId=978912043e310, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c626397577, createdName=ms7000001942545043, createdTime=Sun Mar 20 16:57:51 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204011, encodeId=e5641204011ea, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c0b6157478, createdName=ms3000000367833399, createdTime=Sat Mar 19 12:26:34 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189368, encodeId=16e8118936832, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:46:10 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-03-19 ms3000000367833399

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1232248, encodeId=7970123224832, content=下载的文献是肺癌治疗的,不要下载了,标题与内容不符合。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5d78236143, createdName=ms7000000493469464, createdTime=Wed Jul 13 15:21:06 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229596, encodeId=2f671229596cb, content=文不对题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b876453242, createdName=ms1000001105984899, createdTime=Wed Jun 29 23:12:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204373, encodeId=978912043e310, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c626397577, createdName=ms7000001942545043, createdTime=Sun Mar 20 16:57:51 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204011, encodeId=e5641204011ea, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c0b6157478, createdName=ms3000000367833399, createdTime=Sat Mar 19 12:26:34 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189368, encodeId=16e8118936832, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:46:10 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-01-30 120c570cm03暂无昵称

    学习了

    0

拓展阅读

2015 女性下生殖道人乳头瘤病毒感染诊治专家共识

中华医学会妇产科学分会 · 2015-09-30

2023 加拿大指南:人乳头瘤病毒检测阳性的处理及特殊人群指导

加拿大妇科肿瘤学会(The Society of Gynecologic Oncology of Canada (GOC)) · 2023-06-09

2024 法国临床实践建议:人乳头瘤病毒相关癌前肛门病变的筛查

国外肿瘤科相关专家小组(统称) · 2024-01-10